DeepRhythmAI

DeepRhythmAI is a cloud-based software designed for the automated assessment of cardiac arrhythmias, integrating with other medical products as an API to analyze two-lead ECG data. Its scientific methodology relies on automated algorithms applied to ECG waveforms, with its performance validated against recognized industry standards to provide advisory diagnostic interpretations for healthcare professionals.

DeepRhythmAI, a device developed by Medicalgorithmics S.A., has achieved substantial equivalence determination, allowing its marketing as a Class II Programmable Diagnostic Computer. This regulatory clearance, dated December 4, 2024, signifies the device's compliance with established safety and efficacy standards for medical products. The manufacturer is obligated to adhere to ongoing requirements including device registration, listing, good manufacturing practices, and truthful labeling to maintain its market authorization. DeepRhythmAI functions as a cloud-based software, specifically an Application Programming Interface (API), designed to integrate with other medical products for the assessment of cardiac arrhythmias using two-lead ECG data from adult patients. It provides automated analysis results, which are intended for review and confirmation by qualified healthcare professionals, rather than serving as a sole diagnostic tool. The system supports various ambulatory ECG devices and interfaces with other computer-based ECG systems, with its substantial equivalence determination based on performance testing consistent with recognized industry standards. Notably, it is not intended for life-supporting systems or ECG alarm functions.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific algorithms or AI models does DeepRhythmAI utilize for the automated detection and classification of cardiac arrhythmias?; How does the performance, in terms of accuracy and sensitivity, of DeepRhythmAI compare to manual ECG interpretation or other established automated systems in diverse clinical scenarios?; What are the specific data quality requirements or potential limitations of DeepRhythmAI when processing two-lead ECG data from various ambulatory devices?; Beyond its API function, what are the current and planned interoperability capabilities of DeepRhythmAI with broader Electronic Health Record (EHR) systems or other clinical IT infrastructure?; What post-market surveillance or ongoing validation studies are planned to monitor the long-term efficacy and safety of DeepRhythmAI in a real-world clinical setting?